Axogen Finds Permanent CFO
This article was originally published in Clinica
Executive Summary
AxoGen Inc., which develops peripheral nerve injury surgical solutions, appointed Peter Mariani CFO, effective March 1. Mariani replaces Greg Freitag, who has served as interim CFO since August 2015. Freitag will continue as general counsel, senior VP of business development, and as a member of the board of directors. Prior to joining the company, Mariani served as CFO of LensAR Inc., a privately held maker of next-generation femtosecond laser technology for refractive cataract surgery. He also served as CFO at Hansen Medical Inc., which designs and manufactures medical robotics for positioning and control of catheter-based technologies.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.